<p>2026 年 5 月 18 日東部夏令時間凌晨 4:22（MT Newswires）-- Bio-Rad Laboratories（BIO/B）獲得了 Elliott Investment Management 的大額投資，該公司計劃推動這家生命科學工具供應商改善其滯後的股票表現，《華爾街日報》週日援引知情人士的話報道。</p>
<p>據報道，Elliott 還持有德國實驗室設備製造商 Sartorius 的股份，而 Bio-Rad Laboratories（BIO/B）在該公司擁有約 50 億美元的戰略投資。</p>
<p>報告稱，Bio-Rad Laboratories（BIO/B）股票自 2021 年底疫情高峰以來已下跌超過 70%，因銷售和利潤疲軟，公司表現不及同行。</p>
<p>Elliott Investment Management 未立即回應 MT Newswires 的評論請求。</p>
<p>Bio-Rad Laboratories（BIO/B）股票在週一盤前交易中上漲超過 4%。</p>
<p>（市場聊天新聞來源於全球市場專業人士的對話。這些信息被認為來自可靠來源，但可能包含謠言和猜測。準確性無法保證。）</p>
<p>MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的。</p>

Bio-Rad實驗室-A

<p>Bio-Rad 實驗室獲得了 Elliott 投資管理公司的重大投資，旨在提升公司的股票表現。自 2021 年底以來，由於銷售和利潤下降，Bio-Rad 的股價已暴跌超過 70%。Elliott 還持有 Sartorius 的股份，而 Bio-Rad 在該公司有 50 億美元的投資。消息公佈後，Bio-Rad 的股價在盤前交易中上漲了超過 4%</p>

<p>04:22 AM EDT, 05/18/2026 (MT Newswires) -- Bio-Rad Laboratories ( BIO/B ) has attracted a sizable investment from Elliott Investment Management, which plans to push the life-science tools supplier to improve its lagging stock performance, the Wall Street Journal reported Sunday, citing people familiar with the matter.</p>
<div class="lb-trans"><p>2026 年 5 月 18 日東部夏令時間凌晨 4:22（MT Newswires）-- Bio-Rad Laboratories（BIO/B）獲得了 Elliott Investment Management 的大額投資，該公司計劃推動這家生命科學工具供應商改善其滯後的股票表現，《華爾街日報》週日援引知情人士的話報道。</p>
</div><p>Elliott also holds a stake in German laboratory equipment maker Sartorius, in which Bio-Rad Laboratories ( BIO/B ) owns a strategic investment valued at about $5 billion, according to the report.</p>
<div class="lb-trans"><p>據報道，Elliott 還持有德國實驗室設備製造商 Sartorius 的股份，而 Bio-Rad Laboratories（BIO/B）在該公司擁有約 50 億美元的戰略投資。</p>
</div><p>Bio-Rad Laboratories ( BIO/B ) shares have fallen more than 70% from their pandemic-era peak in late 2021 as sales and profits weakened and the company underperformed peers, the report said.</p>
<div class="lb-trans"><p>報告稱，Bio-Rad Laboratories（BIO/B）股票自 2021 年底疫情高峰以來已下跌超過 70%，因銷售和利潤疲軟，公司表現不及同行。</p>
</div><p>Elliott Investment Management did not immediately respond to MT Newswires' request for comment.</p>
<div class="lb-trans"><p>Elliott Investment Management 未立即回應 MT Newswires 的評論請求。</p>
</div><p>Bio-Rad Laboratories ( BIO/B ) shares were over 4% higher in Monday premarket trading.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories（BIO/B）股票在週一盤前交易中上漲超過 4%。</p>
</div><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p>
<div class="lb-trans"><p>（市場聊天新聞來源於全球市場專業人士的對話。這些信息被認為來自可靠來源，但可能包含謠言和猜測。準確性無法保證。）</p>
</div><p>MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</p>
<div class="lb-trans"><p>MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的。</p>
</div>

市場傳聞：Bio-Rad 實驗室吸引了 Elliott 投資，激進投資者推動其進行轉型